Marion McCourt sold $1.1M of Regeneron Pharmaceuticals (REGN)

Executed Oct 1 2024, disclosed Oct 3 2024, 2 days later.

Value, as filed

$1.1M

1,000 sh × $1,054.06

Executed

Oct 1 2024

the trade date, as filed

Disclosed

Oct 3 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Marion McCourt EVP Commercial profile →

Marion McCourt (EVP Commercial) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $1.1M of REGN (1,000 sh × $1,054.06, as filed), executed Oct 1 2024.

The name

REGN

Regeneron Pharmaceuticals, Inc. REGN · Healthcare · 29 filings in 24 months ticker →

Healthcare · Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Marion McCourt in REGN

REGNSALE Regeneron Pharmaceuticals, Inc. $845K
1,000 sh × $844.61
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET